Zantac users diagnosed with cancer may be entitled to compensation

Zantac was pulled from store shelves two years ago because its use was linked to various forms of cancer due to the medication containing a product used in the manufacturing of jet fuel.

The Environmental Protection Agency (EPA) has labeled N-nitrosodimethylamine (NDMA) as a probable carcinogen. Furthermore, the Food and Drug Administration (FDA) found the heartburn medication’s use of NDMA could lead to cancer in humans, if taken in a high doses. Sanofi, the manufacturer of the brand-name version of Zantac, recalled its product in 2019. Since then, the company reformulated its recipe, as new versions of the drug sold on shelves today do not contain the cancer-causing chemical.

Brian Kelley, an Associate with Kelley & Ferraro, joined the America’s Work Force Union Podcast to discuss the lawsuits filed against Sanofi by people who used Zantac and developed cancer, as well as other lawsuits by relatives of people who passed away after using Zantac and developing cancer. Continue reading

Kelley & Ferraro lawyer discusses Zantac and Philips CPAP recalls

Joyce Reichard, an Associate at Kelley & Ferraro, joined the America’s Work Force Union Podcast to discuss the Zantac and Philips CPAP recalls, both of which have spurred numerous lawsuits because of their potentially cancer causing effects. Continue reading